SEC Filings

  • 111 Inc. announces change to ADS ratio
    • ByInvesting.com
  • Azul reports high participation in exchange offers
    • ByInvesting.com
  • BioCryst adjusts price of ORLADEYO in the U.S.
    • ByInvesting.com
  • Mexico Fund Inc reports monthly summary to SEC
    • ByInvesting.com
  • BioXcel Therapeutics amends executive compensation
    • ByInvesting.com
  • American Battery Tech regains Nasdaq compliance
    • ByInvesting.com
  • Poseida Therapeutics acquired by Roche Holdings
    • ByInvesting.com
  • Versus Systems addresses Nasdaq compliance issues
    • ByInvesting.com
  • Alpha Modus appoints new Chief Revenue Officer
    • ByInvesting.com
  • BIT Mining reports outcomes of annual meeting
    • ByInvesting.com
  • Airgain extends headquarters lease through 2031
    • ByInvesting.com
  • Novonix announces location for new graphite plant
    • ByInvesting.com
  • BCB Bancorp issues new series K preferred stock
    • ByInvesting.com
  • Dynex Capital corrects CEO's LinkedIn misstatement
    • ByInvesting.com
  • Catheter Precision appoints new CFO
    • ByInvesting.com
  • Mastech Digital announces board member changes
    • ByInvesting.com
  • Exxon Mobil reports 4Q24 earnings considerations
    • ByInvesting.com
  • Eastern Bankshares announces board resignations
    • ByInvesting.com
  • Potbelly appoints KPMG as new auditor for FY 2025
    • ByInvesting.com
  • First Keystone announces executive transition
    • ByInvesting.com
  • F&G Annuities prices $375M in subordinated notes
    • ByInvesting.com
  • Sensei Biotherapeutics faces Nasdaq delisting risk
    • ByInvesting.com
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.